Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miray Aydoğan
Observed name:
Miray Aydogan
Institutions:
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
Observed institutions:
Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi
ORCID:
0000-0002-1537-3796
Observed ORCID:
0000-0002-1537-3796
OpenAlex ID:
A5136781406
Association Between Body Mass Index and Clinical Outcomes of CDK4/6 Inhibitors in HR+/HER2− Metastatic Breast Cancer: A Real-World Cohort Study
2026
·
Seval Orman
, Miray Aydoğan
, et al.
·
Journal of Clinical Medicine
·
1
PDF
Adjuvant Chemotherapy and Chemoradiotherapy in Gastric Cancer: Prognostic Determinants and Real-World Survival Outcomes
2026
·
Sedat Yildirim
, Hatice Odabas
, et al.
·
Journal of Clinical Medicine
·
1
PDF
First-Line Durvalumab–Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey
2026
·
Mustafa Murat Midik
, Gökhan Şahin
, et al.
·
Journal of Clinical Medicine
PDF
Maintenance pemetrexed after platinum pemetrexed chemotherapy and survival outcomes in malignant pleural mesothelioma in a multicenter real world study
2026
·
Okan Aydin
, Zehra Sucuoglu Isleyen
, et al.
·
Scientific Reports
PDF
Association Between Metastatic Patterns and Overall Survival in Metastatic Gastric Cancer: A Single-Centre Real-World Study
2026
·
Seval Orman
, Hamit Bal
, et al.
·
The European Research Journal
PDF
Prognostic Significance of Preoperative PET-CT SUVmax in Resected Non-Small Cell Lung Cancer: A Single-Center Retrospective Study
2026
·
Alper Yaşar
, Zeynep Yüksel Yaşar
, et al.
·
Medicina
Outcomes of CDK4 /6 Inhibitor‐Based Therapy in Premenopausal HR +/ HER2 − Metastatic Breast Cancer: Real World Data From A Multicenter Study
2026
·
Hatice Odabaş
, Omar Alomari
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Show more works
View as search
Works count:
7
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type